Medivir to sell BioPhausia to Karo Pharma

01-11-2016

Medivir to sell BioPhausia to Karo Pharma

Pressmaster / shutterstock.com

Sweden-based pharmaceutical company Medivir has entered into an agreement with Karo Pharma, also based in Sweden, under which Medivir will sell its subsidiary BioPhausia to Karo.


Medivir, BioPhausia, Karo Pharma, divestiture, mergers and acquisition

LSIPR